Agoracom interviews CEOs of small cap companies. In this episode of the Small Cap CEO Interviews podcast, AGORACOM speaks with Valeo Pharma (CSE:VPH) CEO, Steve Saviuk. Valeo Pharma Obtains Public Reimbursement For Asthma Drugs In Alberta, One step Closer to 2025 Revenue Target of $160 Million Valeo Pharma is already a successful, revenue generating, small […]